|
US2802005A
(en)
|
|
1957-08-06 |
|
S-eluorourace |
|
US2331725A
(en)
|
1941-01-31 |
1943-10-12 |
Lederle Lab Inc |
Preparation of 2-methyl-1,4-naphthoquinone
|
|
US3205220A
(en)
|
1961-10-26 |
1965-09-07 |
Lilly Co Eli |
Leurosidine and leurocristine and their production
|
|
CH514578A
(de)
|
1968-02-27 |
1971-10-31 |
Sandoz Ag |
Verfahren zur Herstellung von Glucosiden
|
|
GB1457632A
(en)
|
1974-03-22 |
1976-12-08 |
Farmaceutici Italia |
Adriamycins
|
|
DD159877A1
(de)
|
1981-06-12 |
1983-04-13 |
Wolfgang Krueger |
Verfahren zur herstellung von 4-[1-methyl-5-bis(2-chloraethyl)amino-benzimidazolyl-2]-buttersaeure
|
|
OA07174A
(fr)
|
1981-08-24 |
1984-04-30 |
May & Baker Ltd |
Nouvelles imidazotétrazionones, leur préparation et les médicaments qui les contiennent.
|
|
US4526988A
(en)
|
1983-03-10 |
1985-07-02 |
Eli Lilly And Company |
Difluoro antivirals and intermediate therefor
|
|
ES8604088A1
(es)
|
1985-06-14 |
1986-01-16 |
Espanola Farma Therapeut |
Procedimiento para la obtencion de un compuesto derivado de un acido dicarboxilico
|
|
FR2601676B1
(fr)
|
1986-07-17 |
1988-09-23 |
Rhone Poulenc Sante |
Procede de preparation du taxol et du desacetyl-10 taxol
|
|
FR2601675B1
(fr)
|
1986-07-17 |
1988-09-23 |
Rhone Poulenc Sante |
Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
US5004758A
(en)
|
1987-12-01 |
1991-04-02 |
Smithkline Beecham Corporation |
Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
|
|
IL96531A
(en)
|
1989-12-11 |
1995-08-31 |
Univ Princeton |
History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them)
|
|
US5369108A
(en)
|
1991-10-04 |
1994-11-29 |
Sloan-Kettering Institute For Cancer Research |
Potent inducers of terminal differentiation and methods of use thereof
|
|
WO1994006802A1
(fr)
|
1992-09-18 |
1994-03-31 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Compose de thienodiazepine et son utilisation medicinale
|
|
IL117684A
(en)
|
1995-04-07 |
2002-02-10 |
Pharmacia & Upjohn Inc |
Intermediates and Process for Production of History of Kempotocin (CPT-11) and Related Compounds
|
|
JP3354090B2
(ja)
|
1996-09-30 |
2002-12-09 |
シエーリング アクチエンゲゼルシャフト |
分化誘導剤
|
|
US6174905B1
(en)
|
1996-09-30 |
2001-01-16 |
Mitsui Chemicals, Inc. |
Cell differentiation inducer
|
|
RS49779B
(sr)
|
1998-01-12 |
2008-06-05 |
Glaxo Group Limited, |
Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
|
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
|
GB0108591D0
(en)
|
2001-04-05 |
2001-05-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
ES2382377T3
(es)
|
2003-05-30 |
2012-06-07 |
Gemin X Pharmaceuticals Canada Inc. |
Compuestos triheterocíclicos, composiciones, y métodos para tratar cáncer
|
|
WO2005049593A2
(en)
|
2003-11-13 |
2005-06-02 |
Abbott Laboratories |
N-acylsulfonamide apoptosis promoters
|
|
AP2379A
(en)
|
2004-03-23 |
2012-03-08 |
Pfizer Prod Inc |
Imidazole compounds for the treatment of neurodegenerative disorders.
|
|
US7893278B2
(en)
|
2004-06-17 |
2011-02-22 |
Hoffman-La Roche Inc. |
CIS-imidazolines
|
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
|
BRPI0514504A
(pt)
|
2004-08-20 |
2008-06-10 |
Univ Michigan |
pequenas moléculas inibidoras de membros da famìlia bcl-2 anti-apoptóticos e os usos das mesmas
|
|
WO2006028958A2
(en)
|
2004-09-02 |
2006-03-16 |
Genentech, Inc. |
Pyridyl inhibitors of hedgehog signalling
|
|
US7741086B2
(en)
|
2004-12-16 |
2010-06-22 |
President And Fellows Of Harvard College |
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
|
|
ATE476970T1
(de)
|
2005-02-18 |
2010-08-15 |
Universitaetsklinikum Freiburg |
Kontrolle der androgen rezeptor-abhängigen gen expression durch hemmung der aminoxidase aktivität der lysin spezifischen demethylase (lsd1)
|
|
JP5117374B2
(ja)
|
2005-03-29 |
2013-01-16 |
イコス・コーポレイション |
Ｃｈｋ１阻害に有用なヘテロアリール尿素誘導体
|
|
TWI375673B
(en)
|
2005-04-11 |
2012-11-01 |
Abbott Lab |
1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
|
|
ES2493466T3
(es)
|
2005-05-12 |
2014-09-11 |
Abbvie Bahamas Ltd. |
Promotores de la apoptosis
|
|
WO2007015632A1
(en)
|
2005-08-04 |
2007-02-08 |
Cgk Co., Ltd. |
Atm and atr inhibitor
|
|
EP1940773B1
(en)
|
2005-08-10 |
2015-03-18 |
Johns Hopkins University |
Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
|
|
NL2000613C2
(nl)
|
2006-05-11 |
2007-11-20 |
Pfizer Prod Inc |
Triazoolpyrazinederivaten.
|
|
CL2007003244A1
(es)
|
2006-11-16 |
2008-04-04 |
Millennium Pharm Inc |
Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
|
|
EP2142287A4
(en)
|
2007-04-13 |
2012-05-23 |
Univ Johns Hopkins |
INHIBITORS OF LYSINPECIFIC DEMETHYLASE
|
|
CN101868446A
(zh)
|
2007-09-25 |
2010-10-20 |
托波塔吉特英国有限公司 |
某些异羟肟酸化合物的合成方法
|
|
EP2307003A2
(en)
|
2008-05-16 |
2011-04-13 |
Pharma Mar S.A. |
Combination therapy with pm00104 and another antitumor agent
|
|
EP2317992A2
(en)
|
2008-07-24 |
2011-05-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Preventing or treating viral infection using an inhibitor of the lsd1 protein, a mao inhibitor or an inhibitor of lsd1 and a mao inhibitor
|
|
KR101129088B1
(ko)
|
2008-09-17 |
2012-03-23 |
노파르티스 아게 |
Ｎ-［6-(시스-2,6-디메틸모르폴린-4-일)피리딘-3-일］-2-메틸-4'-(트리플루오로메톡시)［1,1'-비페닐］-3-카르복스아미드의 염
|
|
WO2010043721A1
(en)
|
2008-10-17 |
2010-04-22 |
Oryzon Genomics, S.A. |
Oxidase inhibitors and their use
|
|
US8993808B2
(en)
|
2009-01-21 |
2015-03-31 |
Oryzon Genomics, S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
|
ES2546294T7
(es)
|
2009-05-26 |
2024-06-06 |
Abbvie Ireland Unlimited Co |
Agentes inductores de la apoptosis para el tratamiento de cáncer y enfermedades inmunitarias y autoinmunitarias
|
|
US8389580B2
(en)
|
2009-06-02 |
2013-03-05 |
Duke University |
Arylcyclopropylamines and methods of use
|
|
EP2258865A1
(en)
|
2009-06-05 |
2010-12-08 |
Universitätsklinikum Freiburg |
Lysine-specific demethylase 1 (LSD1) is a biomarker for breast cancer
|
|
JPWO2010143582A1
(ja)
|
2009-06-11 |
2012-11-22 |
公立大学法人名古屋市立大学 |
フェニルシクロプロピルアミン誘導体及びｌｓｄ１阻害剤
|
|
AR077014A1
(es)
|
2009-06-19 |
2011-07-27 |
Lilly Co Eli |
Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
|
|
AU2010284221B2
(en)
|
2009-08-18 |
2016-09-22 |
Casero, Robert A |
(bis) urea and (bis) thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders
|
|
WO2011035941A1
(en)
|
2009-09-25 |
2011-03-31 |
Oryzon Genomics S.A. |
Lysine specific demethylase-1 inhibitors and their use
|
|
US8946296B2
(en)
|
2009-10-09 |
2015-02-03 |
Oryzon Genomics S.A. |
Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
PL2526093T3
(pl)
|
2010-01-22 |
2017-02-28 |
Acetylon Pharmaceuticals, Inc. |
Odwrócone związki amidowe jako inhibitory deacetylazy białkowej oraz sposoby ich stosowania
|
|
WO2011106574A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Inhibitors for antiviral use
|
|
WO2011106106A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
|
US20130197088A1
(en)
|
2010-03-12 |
2013-08-01 |
Robert A. Casero, JR. |
Compositions and Methods for Combinations of Oligoamines with 2-Difluoromethylornithine (DFMO)
|
|
RS55348B1
(sr)
|
2010-04-19 |
2017-03-31 |
Oryzon Gnomics S A |
Inhibitori lizin specifične demetilaze-1 i njihova upotreba
|
|
US8765820B2
(en)
|
2010-04-20 |
2014-07-01 |
Universita Degli Studi Di Roma “La Sapienza” |
Tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and/or LSD2
|
|
US8846935B2
(en)
|
2010-05-07 |
2014-09-30 |
Glaxosmithkline Llc |
Indazoles
|
|
MX2012012966A
(es)
|
2010-05-07 |
2013-01-22 |
Glaxosmithkline Llc |
Indoles.
|
|
WO2011143651A1
(en)
|
2010-05-14 |
2011-11-17 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating metabolism
|
|
EP2598480B1
(en)
|
2010-07-29 |
2019-04-24 |
Oryzon Genomics, S.A. |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
|
DK2598482T3
(en)
|
2010-07-29 |
2018-06-14 |
Oryzon Genomics Sa |
ARYLCYCLOPROPYLAMINE-BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE
|
|
WO2012034116A2
(en)
|
2010-09-10 |
2012-03-15 |
The Johns Hopkins University |
Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders
|
|
US20130303545A1
(en)
|
2010-09-30 |
2013-11-14 |
Tamara Maes |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
|
WO2012045883A1
(en)
|
2010-10-08 |
2012-04-12 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
|
GB201112607D0
(en)
|
2011-07-22 |
2011-09-07 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2012072713A2
(en)
|
2010-11-30 |
2012-06-07 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
|
|
CN103391939B
(zh)
|
2010-12-03 |
2016-03-09 |
Epizyme股份有限公司 |
作为表观遗传酶调节剂的经取代的嘌呤和7-氮杂嘌呤化合物
|
|
US20140163041A1
(en)
|
2011-02-08 |
2014-06-12 |
Oryzon Genomics S.A. |
Lysine demethylase inhibitors for myeloproliferative or lymphoproliferative diseases or disorders
|
|
EP2712315B1
(en)
|
2011-02-08 |
2021-11-24 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for myeloproliferative disorders
|
|
EP2677865A4
(en)
|
2011-02-23 |
2015-04-22 |
Icahn School Med Mount Sinai |
BROMODOMAIN INHIBITORS AS MODULATORS OF GENE EXPRESSION
|
|
WO2012118812A2
(en)
|
2011-02-28 |
2012-09-07 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
TWI530489B
(zh)
|
2011-03-22 |
2016-04-21 |
必治妥美雅史谷比公司 |
雙（氟烷基）－１，４－苯二氮呯酮化合物
|
|
MX347913B
(es)
|
2011-03-25 |
2017-05-17 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Ciclopropilaminas como inhibidores de desmetilasa 1 especifica de lisina.
|
|
JO3363B1
(ar)
|
2011-04-13 |
2019-03-13 |
Epizyme Inc |
مركبات بنزين مستبدلة بأريل أو أريل غير متجانس
|
|
WO2012156531A2
(en)
|
2011-05-19 |
2012-11-22 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for inflammatory diseases or conditions
|
|
EP2750671A2
(en)
|
2011-05-19 |
2014-07-09 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for thrombosis and cardiovascular diseases
|
|
AR087107A1
(es)
|
2011-07-27 |
2014-02-12 |
Lilly Co Eli |
Compuesto inhibidor de la señalizacion de la trayectoria notch
|
|
BR112014002939A2
(pt)
|
2011-08-09 |
2017-03-01 |
Takeda Pharmaceuticals Co |
composto, medicamento, método para profilaxia ou tratamento de doença, a doença sendo esquizofrenia, alzheimer, parkinson ou huntington, uso do composto, e, método para inibir o lsd1
|
|
AU2012296639B2
(en)
|
2011-08-15 |
2016-06-09 |
University Of Utah Research Foundation |
Substituted (E)-N'-(1-phenylethylidene) benzohydrazide analogs as histone demethylase inhibitors
|
|
US9469597B2
(en)
*
|
2011-10-20 |
2016-10-18 |
Oryzon Genomics S.A. |
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
|
|
AU2012324803B9
(en)
|
2011-10-20 |
2017-08-24 |
Oryzon Genomics, S.A. |
(hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
|
|
US9085583B2
(en)
|
2012-02-10 |
2015-07-21 |
Constellation—Pharmaceuticals, Inc. |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
|
WO2013178821A1
(en)
|
2012-06-01 |
2013-12-05 |
Leibniz-Institut für Altersforschung - Fritz-Lipmann-Institut e.V. (FLI) |
Inhibitors of the notch signalling pathway and secretion for use in medicine
|
|
EP2907802B1
(en)
|
2012-10-12 |
2019-08-07 |
Takeda Pharmaceutical Company Limited |
Cyclopropanamine compound and use thereof
|
|
WO2014084298A1
(ja)
|
2012-11-28 |
2014-06-05 |
京都府公立大学法人 |
リシン構造を有するｌｓｄ1選択的阻害薬
|
|
US9144555B2
(en)
|
2012-11-30 |
2015-09-29 |
Darlene E. McCord |
Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition
|
|
EP2740474A1
(en)
|
2012-12-05 |
2014-06-11 |
Instituto Europeo di Oncologia S.r.l. |
Cyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a
|
|
JP2016510039A
(ja)
|
2013-02-28 |
2016-04-04 |
ワシントン・ユニバーシティＷａｓｈｉｎｇｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ |
ブロモドメイン阻害剤によるヒトサイトメガロウイルス感染および疾患の治療方法
|
|
WO2014164867A1
(en)
|
2013-03-11 |
2014-10-09 |
Imago Biosciences |
Kdm1a inhibitors for the treatment of disease
|
|
JP2016517434A
(ja)
|
2013-03-14 |
2016-06-16 |
エピザイム，インコーポレイティド |
癌を処置するための併用療法
|
|
US9918983B2
(en)
|
2013-05-30 |
2018-03-20 |
The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas |
Suicidal LSD1 inhibitors targeting SOX2-expressing cancer cells
|
|
CN105555784B
(zh)
|
2013-06-19 |
2019-03-15 |
犹他大学研究基金会 |
作为组蛋白去甲基化酶抑制剂的被取代的(e)-n’-(1-苯亚乙基)苯甲酰肼类似物
|
|
EP2829284A1
(en)
|
2013-07-22 |
2015-01-28 |
Deutsches Krebsforschungszentrum |
Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor
|
|
JP6521967B2
(ja)
|
2013-08-06 |
2019-05-29 |
イマーゴ バイオサイエンシーズ インコーポレイテッド |
疾患の治療のためのｋｄｍ１ａ阻害剤
|
|
WO2015031564A2
(en)
|
2013-08-30 |
2015-03-05 |
University Of Utah |
Substituted-1h-benzo[d]imidazole series compounds as lysine-specfic demethylase 1 (lsd1) inhibitors
|
|
MX373187B
(es)
|
2013-12-06 |
2020-04-13 |
Epizyme Inc |
Terapia de combinación para tratar cáncer.
|
|
CA3161836A1
(en)
|
2013-12-11 |
2015-06-18 |
Celgene Quanticel Research, Inc. |
Inhibitors of lysine specific demethylase-1
|
|
WO2015120281A1
(en)
|
2014-02-07 |
2015-08-13 |
Musc Foundation For Research Development |
Aminotriazole- and aminotetrazole-based kdm1a inhibitors as epigenetic modulators
|
|
LT3105218T
(lt)
|
2014-02-13 |
2019-12-10 |
Incyte Corp |
Ciklopropilaminai kaip lsd1 inhibitoriai
|
|
US9527835B2
(en)
|
2014-02-13 |
2016-12-27 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
|
WO2015123424A1
(en)
|
2014-02-13 |
2015-08-20 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
EP3392244A1
(en)
|
2014-02-13 |
2018-10-24 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
JP2017508798A
(ja)
*
|
2014-03-07 |
2017-03-30 |
ザ ジョンズ ホプキンス ユニバーシティ |
ヒストンリジン特異的デメチラーゼ（ｌｓｄ１）およびヒストンデアセチラーゼ（ｈｄａｃ）の阻害剤
|
|
NZ725262A
(en)
|
2014-04-11 |
2023-01-27 |
Takeda Pharmaceuticals Co |
Cyclopropanamine compound and use thereof
|
|
WO2015168466A1
(en)
|
2014-05-01 |
2015-11-05 |
Quanticel Pharmaceuticals, Inc. |
Inhibitors of lysine specific demethylase-1
|
|
MX375102B
(es)
|
2014-05-30 |
2025-03-06 |
Ieo St Europeo Di Oncologia S R L |
Compuestos de ciclopropilamina como inhibidores de histona demetilasa
|
|
PL3160956T3
(pl)
|
2014-06-27 |
2020-11-30 |
Celgene Quanticel Research, Inc. |
Inhibitory demetylazy-1 specyficznej dla lizyny
|
|
EA201790082A1
(ru)
|
2014-07-03 |
2017-08-31 |
Селджен Квонтисел Рисёрч, Инк. |
Ингибиторы лизин-специфической демитилазы-1
|
|
WO2016003917A1
(en)
|
2014-07-03 |
2016-01-07 |
Quanticel Pharmaceuticals, Inc. |
Inhibitors of lysine specific demethylase-1
|
|
WO2016007736A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyrazines as lsd1 inhibitors
|
|
WO2016007722A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
US9758523B2
(en)
|
2014-07-10 |
2017-09-12 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as LSD1 inhibitors
|
|
WO2016007731A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyridines and imidazopyrazines as lsd1 inhibitors
|
|
US20170232030A1
(en)
*
|
2014-08-13 |
2017-08-17 |
Epizyme, Inc. |
Combination therapy for treating cancer
|
|
EP2993175A1
(en)
|
2014-09-05 |
2016-03-09 |
IEO - Istituto Europeo di Oncologia Srl |
Thienopyrroles as histone demethylase inhibitors
|
|
ES2935114T3
(es)
|
2014-09-05 |
2023-03-01 |
Celgene Quanticel Res Inc |
Inhibidores de la desmetilasa 1 específica de lisina
|
|
EP3250552B1
(en)
|
2015-01-30 |
2019-03-27 |
Genentech, Inc. |
Therapeutic compounds and uses thereof
|
|
JP6727216B2
(ja)
|
2015-02-12 |
2020-07-22 |
イマーゴ バイオサイエンシーズ インコーポレイテッド |
疾患の治療のためのｋｄｍ１ａ阻害剤
|
|
CN106146361A
(zh)
|
2015-03-16 |
2016-11-23 |
四川大学 |
茚-1-亚基磺酰基苯甲酰肼衍生物及其制备方法和用途
|
|
EA201792205A1
(ru)
|
2015-04-03 |
2018-02-28 |
Инсайт Корпорейшн |
Гетероциклические соединения как ингибиторы lsd1
|
|
CN106045862B
(zh)
|
2015-04-10 |
2019-04-23 |
上海迪诺医药科技有限公司 |
环丙胺类螺(杂)环化合物、其药物组合物及应用
|
|
EP3286172B1
(en)
|
2015-04-23 |
2019-06-12 |
Constellation Pharmaceuticals, Inc. |
Lsd1 inhibitors and uses thereof
|
|
EP3090998A1
(en)
|
2015-05-06 |
2016-11-09 |
F. Hoffmann-La Roche AG |
Solid forms
|
|
KR20180011331A
(ko)
|
2015-06-12 |
2018-01-31 |
오리존 지노믹스 에스.에이. |
Lsd1 억제제와 관련된 바이오마커 및 그의 용도
|
|
US20170001970A1
(en)
|
2015-07-02 |
2017-01-05 |
University Of Utah Research Foundation |
Substituted benzohydrazide analogs as histone demethylase inhibitors
|
|
WO2017013061A1
(en)
|
2015-07-17 |
2017-01-26 |
Oryzon Genomics, S.A. |
Biomarkers associated with lsd1 inhibitors and uses thereof
|
|
DK3334709T3
(da)
|
2015-08-12 |
2025-02-03 |
Incyte Holdings Corp |
Salte af en lsd1-hæmmer
|
|
CN105233292B
(zh)
*
|
2015-10-19 |
2018-03-13 |
中国科学院北京基因组研究所 |
Ory‑1001联合放疗和化疗用于治疗人三阴性乳腺癌的用途
|
|
CN105541806A
(zh)
|
2015-12-25 |
2016-05-04 |
中国药科大学 |
巴比妥酸类化合物、制备方法及其应用
|
|
CN105924362B
(zh)
|
2016-02-05 |
2018-08-17 |
上海龙翔生物医药开发有限公司 |
芳香环丙基胺类化合物、其药学上可接受的盐、其制备方法及其用途
|
|
SG10201913290QA
(en)
|
2016-03-15 |
2020-03-30 |
Oryzon Genomics Sa |
Combinations of lsd1 inhibitors for the treatment of hematological malignancies
|
|
CN120661674A
(zh)
|
2016-03-15 |
2025-09-19 |
奥莱松基因组股份有限公司 |
用于治疗实体瘤的lsd1抑制剂的组合
|
|
JP2019512546A
(ja)
|
2016-03-16 |
2019-05-16 |
オリゾン・ゲノミクス・ソシエダッド・アノニマ |
Ｋｄｍ１ａ標的会合を決定するための方法、およびそれに有用な化学プローブ
|
|
CN106045881B
(zh)
|
2016-05-26 |
2017-10-31 |
新乡医学院 |
一类白藜芦醇衍生物、其制备方法及作为lsd1抑制剂的应用
|